CFO
Gufic Biosciences Limited
Equibles does not estimate personal net worth.
Devkinandar Rumta is recorded as CFO at Gufic Biosciences Limited. Devkinandar Rumta has spoken on 1 earnings call across 1 company, most recently for Gufic Biosciences Limited on August 17, 2026. Gufic Biosciences Limited is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector.
“In beta margin in Q1 of 25-26 was 14.6%, whereas Q1 of 26-27 is 18.09%. Profit before tax in Q1 was 16.3 crores, whereas Q1 of 26-27 is 30.1 crores. The PAC margin in Q1 2526 was 7.1%.”
Gufic Biosciences Limited
CFO
Transcript header (unverified)
Gufic Biosciences Limited
Drug Manufacturers - Specialty & Generic · Healthcare
CFO
Earnings Call
Gufic Biosciences Limited
